An open, non comparative study of ofloxacin i.v. on the treatment of acute symptomatic urinary tract infection.
Artigo
em Inglês
| IMSEAR
| ID: sea-39637
ABSTRACT
The clinical efficacy and the safety of ofloxacin i.v. in 35 acute symptomatic urinary tract patients were evaluated. The drug was intravenously administered, 400 mg starting dose then 200 mg once-daily for 3-5 days. The therapeutic success rate and eradication rate in UTI case were 100 per cent in all cases when evaluated immediately after completion of drug treatment, therapeutic success rate and eradication rate at the follow-up evaluation were 97.2 per cent and 91.6 per cent respectively. Also, 5 cases of acute bronchitis and 2 salmonellosis were also administered intravenously, 400 mg once-daily dose and 400 mg twice daily dose respectively. No serious side effects of ofloxacin i.v. therapy were observed in any of our patients.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Prognóstico
/
Infecções Bacterianas
/
Infecções Urinárias
/
Idoso
/
Feminino
/
Humanos
/
Masculino
/
Esquema de Medicação
/
Ofloxacino
/
Doença Aguda
Tipo de estudo:
Estudo prognóstico
Idioma:
Inglês
Ano de publicação:
2000
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS